Update on vaginal micronised progesterone soft gel capsule for unexplained threatened miscarriage

Description

In this Product Explainer, Obstetrician and Gynaecologist Dr Hugh Porter explains the role of vaginal micronised progesterone, including the indication, safety profile, clinical trial background and guidelines for use for the treatment and management of threatened miscarriage (6 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Emily Nash

Dr Emily Nash

Abnormal Liver Function Test

Prof Andrew Sindone AM

Prof Andrew Sindone AM

Heart Failure Exacerbation – Important Management Steps After Hospital Discharge

Prof Michelle Giles OAM

Prof Michelle Giles OAM

Practical Strategies to Address Falling Vaccination Rates in Mums and Bubs

Prof Richard Harvey

Prof Richard Harvey

Recurrent Nasal Polyps Management – When to Refer

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Hugh Porter

expert

Dr Hugh Porter

Obstetrician and Gynaecologist

Date published: 23 September 2025